Thinking about selling your independent pharmacy in San Antonio, Texas?
A private, confidential way to find out whether your independent pharmacy business fits an active buyer, without a public listing, a broker blast, or your team finding out.
Buyer demand on Serava
3 buyers have told Serava they want to buy pharmacies in the US.
See which of them fit your business. No buyer learns your name without your OK.
Counted since April 2026. Each buyer counted once. Our own and test accounts excluded.
Private and confidential, never a public listing.
No broker blast, and never an automatic introduction.
A real conversation only if there is genuine fit.
Looking to buy, not sell? Build a target map with /try.
Looking to sell? Email us at sadra@serava.ai with a few lines: what the business does, roughly where it stands today, and what prompted you to think about a sale.
What a buyer actually checks
Independent retail, compounding, closed-door, LTC, specialty, or community pharmacy
License, payer mix, script volume, gross margin, and inventory profile can be reviewed
Owner-pharmacist involvement and staff pharmacist coverage are clear
Texas market intelligence
Regional pharmacy platforms headquartered in Dallas, Houston, and Austin are actively searching for independent operators in San Antonio because the market sits at a critical density threshold: 29 tracked pharmacies across the metro creates enough geographic coverage to justify operational infrastructure without the saturation that makes individual locations hard to improve. These platforms need San Antonio specifically to anchor their south-central Texas presence and fill gaps between their existing locations in Austin and Corpus Christi, where route consolidation actually saves money on delivery and licensing compliance. National consolidators like Walgreens Health Initiatives and smaller DSOs are also active, but they pursue San Antonio stores only when tied to specific health system partnerships or when a seller operates in medical corridors around UT Health San Antonio or Methodist Hospital. The buyers who pay premiums here are typically regional platforms with 15 to 40 locations already operating in Texas, because San Antonio pharmacies reduce their distribution costs immediately and because they can transplant their back-office operations directly into a new acquisition without building new infrastructure from scratch. A San Antonio pharmacy owner's outcome depends entirely on whether their location and customer base survive what comes next. Pharmacies clustered near the Medical Center or in high-density residential corridors like Stone Oak command stronger pricing because a buyer can optimize delivery and staff coverage across multiple sites; a standalone location on the city's perimeter becomes harder to value because the buyer absorbs transition risk with no nearby stores to rely on during integration. Texas pharmacy regulations are straightforward compared to coastal states, but San Antonio sellers must document MPJE compliance history, DEA licensing renewals, and any state board correspondence in advance because national buyers specifically scrutinize Texas credential management. Customer concentration in independent pharmacy weighs heavily here: if 40 percent of scripts come from one employer group or senior living facility, a buyer immediately models risk around contract renewal or price negotiations. Before any buyer meeting, a San Antonio owner should have three years of aggregated dispensing data by payor mix, documented staff retention rates, and a clear picture of prescription volumes by indication, because buyers in this market use that data to forecast what they can realistically retain after transition and whether they need to invest in new clinical services to compete against chains moving into the same corridor.
Common questions
Can Serava tell me what my independent pharmacy is worth in San Antonio, Texas?
Serava does not promise a valuation, price, buyer, sale, or timeline. The private buyer-fit review organizes the evidence a serious owner may need before any valuation discussion, including revenue quality, customer concentration, owner dependence, and scripts and payer mix.
Can I check buyer interest without a public listing?
Yes. The seller path is built for a private buyer-fit review, not a public listing or broad broker blast. Real contact details are required so confidentiality, owner approval, and next-step fit can be handled manually before any appropriate conversation.
Is this a broker alternative for Independent Pharmacy owners?
It can help owners compare options before committing to a process, but it is not a brokerage engagement, representation agreement, valuation opinion, or promise to replace an advisor. The goal is to understand buyer-interest signal and evidence quality first.
One private step tells you:
- Whether an active buyer actually matches your business
- How you would be positioned, a confidential read, not a sales pitch
- A warm introduction, only if you want it, only if the fit is real
Most owners sell once, and either hand a broker 8 to 10% or take the first unsolicited offer. Knowing who is already buying, before you list, is your leverage. We never publish your business, never blast brokers, and never introduce you automatically.
~2 minutes · no public listing · no obligation · you pay nothing unless you choose to move forward.
Worth/value proof
What serious buyers want to understand
Script volume, refill trend, payer mix, PBM exposure, gross margin, inventory quality, and specialty or LTC niches.
License status, staff pharmacist depth, owner transition plan, compliance history, lease terms, and local patient demand.
Before you talk to a buyer
What buyers check in this industry, what moves the multiple, and what to fix first:
All seller guidesDeal terms, explained
The vocabulary usually arrives all at once, in a letter of intent, with a deadline attached. Plain-English definitions of what each term actually does to your proceeds:
All 44 terms in the M&A glossaryAlso worth a look
Related industries